Pignata, Sandro, Sabrina Chiara Cecere, and Massimo Di Maio. “Bevacizumab As First-Line Treatment of Ovarian Cancer: Strengths and Weaknesses of Subgroup Analyses:  ”. Cancer Breaking News 4, no. 1 (March 15, 2016): 45–47. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/205.